BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 8049889)

  • 1. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM; McHenry L; Sanyal AJ
    Gastroenterologist; 1993 Jun; 1(2):165-9. PubMed ID: 8049889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM; Bytzer P
    Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Miller DR
    Clin Pharm; 1992 Aug; 11(8):690-704. PubMed ID: 1511542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M; Dezi A; Ferrario F; Capurso I
    Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH; Salena BJ; Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM
    J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM; Dajani EZ
    J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
    N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
    Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
    Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.